Want to join the conversation?
$SYK's Neurotechnology and Spine sales for 2015 rose 5% as reported and 9.5% in constant currency, as FX rates negatively impacted sales by 4.5%. Excluding 0.1% impact of acquisitions, sales in constant currency grew 9.4%. The increase was led primarily by higher shipments of neurotechnology products.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.